Jaw osteonecrosis in patients treated with denosumab 120 mg with regular dental monitoring: 4-year retrospective study

• Asıl Yazarlar: Beaudouin Sophie (Yazar), Scailteux Lucie-Marie (Yazar), Lefeuvre Claudia (Yazar), Gamby Romain (Yazar), Cairon-Lejeune Sophie (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: EDP Sciences, 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Medication-related osteonecrosis of the jaw (MRONJ) is an expected, but rare adverse effect of denosumab. There are few data denosumab 120 mg related MRONJ occurrence when regular dental monitoring is planned. International and French recommendations do not detail the schedule of the fol...